VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ADPT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ADPTAdaptive Biotechnologies Corporation
$20.82$3.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksADPTQuarterly Cash Flow

Adaptive Biotechnologies Corporation (ADPT) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Adaptive Biotechnologies Corporation (ADPT) quarterly cash flow statement — complete operating, investing & financing history

ADPT Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Cash from Operations-9.54M2.06M-7.13M-12.43M-28.48M-12.49M-27.07M-17.3M-38.35M-26.93M-46.68M-23.56M-59.15M-30.02M-42.41M-47.06M-64.45M-53.83M-43.44M-37.21M
Operating CF Margin %-13.46%2.87%-7.58%-21.11%-54.31%-26.32%-58.29%-40.06%-91.59%-58.82%-123.12%-48.15%-157.12%-54.38%-88.66%-107.8%-166.89%-141.91%-110.07%-96.64%
Operating CF Growth %66.52%116.45%73.67%28.16%25.73%53.62%42.03%26.55%35.16%10.28%-10.08%49.95%8.22%44.23%2.38%-26.47%-10.66%-35.09%7.87%-19.74%
Net Income-20.02M-13.58M9.55M-25.59M-29.85M-33.72M-32.07M-46.22M-47.51M-69.44M-50.3M-47.81M-57.7M-40.13M-45.28M-52.05M-62.74M-61.43M-56M-49.3M
Depreciation & Amortization3.84M04.41M4.5M4.73M4.45M4.59M5M5.21M5.39M7.62M7.48M5.42M7.09M7.21M7M6.85M6.62M3.53M4.66M
Stock-Based Compensation11.93M12.72M013.36M012.83M00000014.67M0000011.64M0
Deferred Taxes00000000000000000000
Other Non-Cash Items-5.29M5.37M12.79M607K12.78M893K13.44M21.09M14.25M40.63M14.64M16.32M2.93M13.5M15.04M17.46M13.64M13.16M3.55M13.32M
Working Capital Changes0-2.45M-33.87M-5.3M-16.14M3.05M-13.03M2.83M-10.31M-3.51M-18.64M449K-24.48M-10.48M-19.37M-19.48M-22.21M-12.17M-6.17M-5.89M
Change in Receivables2.05M-5.54M-536K-702K-1.86M-899K-5.2M6.41M-4.05M-6.77M334K-621K9.09M-13.51M-2.84M-1.19M-5.11M-287K-2.95M5.58M
Change in Inventory-10K-10K-1.35M95K264K3.38M1.7M-818K1.11M3.98M-273K65K-6.61M3.03M72K-545K-1.74M-1.03M381K-1.19M
Change in Payables-7.51M1.17M5.9M3.27M-9.66M0-59K407K-3.94M5.34M-2.81M7.94M010.53M5.54M-1.41M-7.54M-1.58M04.78M
Cash from Investing9.14M-8.25M17.28M3.35M25.57M22.12M5.29M5.88M44.51M3.21M26.14M37.32M62.98M-97.54M58.02M4.75M37.69M67.21M-21.27M41.45M
Capital Expenditures-796K-636K-409K-655K-1.26M-80K-344K-1.73M-1.51M-1.3M-2.78M-3.7M-2.92M-2.54M-5.43M-5.3M-3.08M-9.24M-14.62M-22.04M
CapEx % of Revenue1.12%0.89%0.44%1.11%2.4%0.17%0.74%4%3.61%2.84%7.33%7.56%7.77%4.61%11.36%12.13%7.97%24.37%37.04%57.24%
Acquisitions00000000000000000000
Investments--------------------
Other Investing00000000000000000000
Cash from Financing7.5M21.66M1.68M1.61M5.45M127K40K30K44K87K17K1.47M672K6K125.52M3.99M2.75M3.28M2.93M6.33M
Debt Issued (Net)0000000000000-316K124.69M00000
Equity Issued (Net)021.66M1.68M1.61M5.45M040K30K44K87K17K1.47M0322K829K3.99M2.75M3.28M-429K6.33M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing7.5M0000127K000000672K000003.35M0
Net Change in Cash7.11M15.46M11.87M-7.47M2.73M9.76M-21.74M-11.41M6.17M-23.65M-20.53M14.63M4.5M-127.52M141.14M-38.39M-24.26M16.66M-61.78M10.56M
Free Cash Flow-10.33M1.42M-7.54M-13.09M-29.74M-12.57M-27.41M-19.03M-39.86M-28.23M-49.46M-27.25M-62.08M-32.56M-47.84M-52.36M-67.53M-63.07M-58.06M-59.25M
FCF Margin %-14.58%1.98%-8.02%-22.22%-56.71%-26.49%-59.03%-44.07%-95.2%-61.66%-130.44%-55.7%-164.89%-58.99%-100.02%-119.93%-174.86%-166.28%-147.12%-153.89%
FCF Growth %65.26%111.29%72.51%31.25%25.39%55.47%44.59%30.17%35.78%13.3%-3.39%47.95%8.08%48.37%17.61%11.63%8.85%-28.16%-13.04%-77.73%
FCF per Share-0.070.01-0.05-0.09-0.20-0.09-0.19-0.13-0.27-0.19-0.34-0.19-0.43-0.23-0.33-0.37-0.48-0.45-0.41-0.42
FCF Conversion (FCF/Net Income)0.48x-0.15x-0.75x0.49x0.95x0.37x0.84x0.37x0.81x0.39x0.93x0.49x1.03x0.75x0.94x0.90x1.03x0.88x0.78x0.75x
Interest Paid000002.32M0000002.76M0000000
Taxes Paid00000000000000000000